KURA vs SYF · rev $20.9M vs rev $11.19B
Kura Oncology Inc (KURA) versus SYF (SYF) — a side-by-side from cached financials, not a winner call.
Kura Oncology Inc (KURA) is a biotechnology company listed on NASDAQ.
SYF (SYF) common stock.
Latest reported KURA revenue for 2026-06-30 was $20.9M. Net income was -$68.3M. Revenue was up 14.3% from 2026-03-31 to 2026-06-30. KURA currently screens at market cap $861.1M.
Latest reported SYF revenue for 2026-06-30 was $11.19B. Net income was $1.69B. Revenue was up 99.6% from 2026-03-31 to 2026-06-30. SYF currently screens at market cap $0.
KURA currently screens at market cap $861.1M. SYF currently screens at market cap $0.
Not investment advice. Open the KURA and SYF stock pages for the full models.
Not investment advice.